Higher doses of laquinimod halted in trials
Posted: Mon Jan 04, 2016 8:29 am
Teva Pharmaceutical Industries and Active Biotech are to discontinue higher doses of their oral drug in development for multiple sclerosis in two trials, citing the occurrence of non-fatal cardiovascular events in eight patients...Read more - http://www.ms-uk.org/MSnews